Optimal planning of phase II/III programs for clinical trials with multiple endpoints

DOI10.1002/PST.1861WikidataQ53397556 ScholiaQ53397556MaRDI QIDQ5978237

Marietta Kirchner, Heiko Götte, Eva Dölger, Meinhard Kieser

Publication date: 26 April 2018

Published in: Pharmaceutical Statistics (Search for Journal in Brave)

Related Items (1)

drugdevelopR

This page was built for publication: Optimal planning of phase II/III programs for clinical trials with multiple endpoints